-
A rapid, ongoing expansion in the number of high-containment biodefense laboratories throughout the nation is raising serious questions about the safety of lab workers, the risk to the public, and the lack of government oversight to prevent accidents and security breaches.
-
As the number of high-containment labs undergoes an unprecedented expansion in the United States, the question of relative risk is coming to the forefront.
-
An exercise designed to test laboratory readiness for a bioterrorism incident turned into a real-life disaster of another sort when specimen mislabeling and flagrant breaches in infection control resulted in numerous exposures to an attenuated vaccine strain of Brucella abortus RB51, the Centers for Disease Control and Prevention reports.
-
The Centers for Disease Control and Prevention is distributing a new-generation smallpox vaccine, ACAM2000 (Acambis, Inc.; Cambridge, MA), to civilian laboratory personnel, the military, and state public health preparedness programs.
-
As this issue of Bioterrorism Watch went to press, the Centers for Disease Control and Prevention (CDC) was investigating a case of ricin exposure in Las Vegas. The CDC said "preliminary results of environmental testing at laboratories in Nevada have tested positive for ricin."
-
-
Duct tape is no more effective than moleskin for the treatment of common warts. Occlusion therapy with both for 7 days will give resolution in just over 20% of patients.
-
Increasing use of CT scans has led to an increase of radiation exposure to its recipients, potentially causing up to 2% of new cancers, especially in children.
-
The FDA has approved extended release niacin plus simvastatin as a combination product.
-
Does Published Evidence Reflect the Whole Story?, Vitamin E levels and Physical Decline with Aging, Effort, Efficacy, and Effectiveness
